Today's pre-market stock movers: DOCU, BGNE, RBLX, SFIX and more
Gainers:
• $Cogent Biosciences (COGT.US)$ +7.9% (announces positive initial clinical data from ongoing phase 2 APEX trial evaluating bezuclastinib in patients with advanced systemic mastocytosis)
• $BeiGene (BGNE.US)$ +5.4% (highlights growing portfolio and pipeline targeting hematologic malignancies at European Hematology Association 2022 Congress)
• $Apellis Pharmaceuticals (APLS.US)$ +5%(Apellis and Sobi Report New Data Reinforcing the Robust Efficacy and Safety Profile of EMPAVELI (pegcetacoplan) for PNH at EHA 2022 Congress)
• $IVERIC bio (ISEE.US)$ +5%(presentation of post-hoc analysis at macula society from GATHER.1 clinical trial of Zimura in Patients with Geographic Atrophy)
• $BlueCity (BLCT.US)$ +3.5% (FDA Advisory Committee unanimously endorses eli-cel gene therapy for cerebral adrenoleukodystrophy)
• $ADC Therapeutics (ADCT.US)$ +3%(reports results from pivotal Phase 2 clinical trial of Camidanlumab Tesirine)
• $Summit Midstream (SMLP.US)$ +2.8% (Summit Midstream Partners divests its Lane Gathering and Processing System in the Delaware Basin to a subsidiary of Matador Resources (MTDR.); reiterates its 2022 Adjusted EBITDA guidance)
• $Amarin (AMRN.US)$ +2.8% (receives positive recommendation from UK's National Institute for Health and Care Excellence for Reimbursement of VAZKEPA)
• $Turtle Beach (HEAR.US)$ +2.3% (co's ROCCAT PC gaming peripherals brand extends partnership with Gen.G Esports)
• $Oceaneering International (OII.US)$ +1.9% (partners with Collins Aerospace for NASA spacesuit program)
• $Autolus Therapeutics (AUTL.US)$ +1.8% (Presents Clinical Data Updates at the European Hematology Association Congress)
• $Kronos Bio (KRON.US)$ +1.6% (Continues to Advance Investigational SYK Inhibitors Entospletinib and Lanraplenib with New Preclinical Data at EHA2022 Congress)
Analyst comments:
Losers:
• $Caribou Biosciences (CRBU.US)$ -14.1% (Reports Additional Data from CB-010 Allogeneic CAR.-T Cell Therapy Phase 1 ANTLER. Trial at the European Hematology Association (EHA) 2022 Hybrid Congress)
• $CTI BioPharma (CTIC.US)$ -9.5% (Presents Pivotal Data from Pacritinib Program at the European Hematology Association (EHA) 2022 Congress)
• $Cadre Holdings (CDRE.US)$ -1.9% (prices primary and secondary offering of common stock at $23.50 per share)
• $MGM Resorts International (MGM.US)$ -1% (to sell Gold Strike Tunica operations to Cherokee Nation for $450 mln)
Analyst comments:
• $Lamar Advertising Co (LAMR.US)$ -1.9% (downgraded to Equal-Weight from Overweight at Morgan Stanley)
Disclaimer: Moomoo Technologies Inc. is providing this content for information and educational use only.
Read more
Comment
Sign in to post a comment
Moomoo News Official Account
Explore and integrate top feeds before the bell
64KFollowers
14Following
64KVisitors
Follow
Angeler : Bimi
Angeler : $BIMI Holdings (BIMI.US)$
Stuka II Angeler : Do you trade theses pre market momentum stocks for often?
Sell The Truth Stuka II : I do. What you got in your bag
Angeler : yes i do so
Stuka II Angeler : Then I think we should have a chat room for this if that’s something you interested. I usually trade those momentum stocks and options just for fun and make some bucks out of it.
Stuka II Sell The Truth : Chat room for sharing stock buying ideas, interested?